7498 Results (Page 219 of 300)
Pharmaceuticals Markets Research Reports
Thailand Obesity Drugs Market Analysis
This report presents a strategic analysis of the Thailand Obesity Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Obesity Drugs Market, offering unmatched value, accuracy, and expert insights.
Thailand Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Thailand Liver Disease Therapeutics market will reach a value of $44 Mn from $28 Mn in 2022, growing at a CAGR of 6% during 2022-2030. Liver Disease Therapeutics in Thailand is dominated by a few domestic pharmaceutical companies such as Mega Lifesciences, BioNet-Asia, and Chulalongkorn Hospital. The Liver Disease Therapeutics market in Thailand is segmented into different types of disease and different therapy types. Some of the major factors affecting the Thailand Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Tanzania HIV Drugs Market Analysis
This report presents a strategic analysis of the Tanzania HIV Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Tanzania HIV Drugs Market, offering unmatched value, accuracy, and expert insights.
Tanzania Dialysis Market Analysis
This report presents a strategic analysis of the Tanzania Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Tanzania Dialysis Market, offering unmatched value, accuracy, and expert insights.
Tanzania Diabetes Therapeutics Market Analysis
Tanzania's diabetes therapeutics market is expected to witness growth from $58 Mn in 2022 to $129 Mn in 2030 with a CAGR of 10.6% for the forecasted year 2022-30. The rising prevalence and the introduction of novel medications for the treatment of diabetes in Tanzania have resulted in the expansion of the market. The Tanzania diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Kairuki Pharmaceuticals, Keko Pharmaceutical, and Eli Lilly are the major players in the Tanzania diabetes therapeutics market.
Tanzania Depression Therapeutics Market Analysis
Tanzania's depression therapeutics market is expected to grow from $4 Mn in 2022 to $6 Mn in 2030 with a CAGR of 6.1% for the forecasted year 2022-2030. The growing demand for effective depression treatments and the rising government initiatives to promote awareness about depression in Tanzania are responsible for the expansion of the market. The Tanzania depression therapeutics market is segmented by drug type, therapies, indication, and end users. Tanga Pharmaceuticals, Afya Bora Pharma, and AbbVie are the major players in the Tanzania depression therapeutics market.
Switzerland Antibacterial (Antibiotics) Drugs Market Analysis
This report presents a strategic analysis of the Switzerland Antibacterial (Antibiotics) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Switzerland Antibacterial (Antibiotics) Drugs Market, offering unmatched value, accuracy, and expert insights.
South Korea Vaccines Market Analysis
This report presents a strategic analysis of the South Korean vaccine market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Korean vaccine market, offering unmatched value, accuracy, and expert insights.
South Korea Oncology Therapeutics Market Analysis
By 2030, the South Korea Oncology Therapeutics Market is anticipated to reach a value of $5.4 Bn from $2.7 Bn in 2022, growing at a CAGR of 9.4% during 2022-30. The Oncology Therapeutics Market in South Korea is dominated by a few domestic pharmaceutical companies such as Celltrion, Green Cross, and Kolon Life Science. The Oncology Therapeutics Market in South Korea is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for South Korea Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
South Africa Radiotherapy Market Analysis
By 2030, it is anticipated that the South African radiotherapy Market will reach a value of $xx Mn from $45 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in South Africa is dominated by a few domestic players such as Acceletronics, Medequip, and Oncovision. The radiotherapy market in South Africa is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for South African radiotherapy is increasing on account of the rise in cancer cases in the country.
South Africa Liver Cancer Therapeutics Market Analysis
By 2030, the South Africa Liver Cancer Therapeutics market is anticipated to reach a value of $75.7 Mn from $19 Mn in 2022, growing at a CAGR of 18.8 % during 2022-30. The Liver Cancer Therapeutics in South Africa is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare, Adcock Ingram, and AstraZeneca South Africa. The Liver Cancer Therapeutics market in South Africa is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South Africa Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Brazil Alzheimer’s Disease Drugs Market Analysis
Brazil's Alzheimer’s disease drugs market was valued at $386 Mn in 2022 and is estimated to expand at a CAGR of 9.42% from 2022-30 and will reach $792 Mn in 2030. One of the main reasons propelling the growth of this market is government support technologies and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Abbvie, AstraZeneca, Aspen, Bristol Myers Squibb, Chiesi Farmaceutici, Daiichi Sankyo Company, Eisai Co., Eurofarma, Ferring, Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer and Teva Pharmaceutical among others.
Canada Alzheimer’s Disease Drugs Market Analysis
Canada's Alzheimer’s disease drugs market was valued at $1.23 Bn in 2022 and is estimated to expand at a CAGR of 8.42% from 2022-30 and will reach $2.35 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Pfizer, Biogen, Eli Lilly and Company, Novartis International AG, Merck & Co, AstraZeneca, Roche Holding AG, Johnson & Johnson, AbbVie, and Sanofi among others.
France Alzheimer’s Disease Drugs Market Analysis
The France Alzheimer’s Disease Drugs market was valued at $424 Mn in 2022 and is estimated to expand at a CAGR of 7.42% from 2022-30 and will reach $752 Mn in 2030. One of the main reasons propelling the growth of this market is government support, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Alexion Pharma, Takeda Pharmaceuticals, Biogen, Daiichi Sankyo Company, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer, and Teva Pharmaceutical among others.
Germany Alzheimer’s Disease Drugs Market Analysis
Germany's Alzheimer’s Disease Drugs market was valued at $564 Mn in 2022 and is estimated to expand at a CAGR of 6.62% from 2022-30 and will reach $942 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer drugs, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AbbVie, AstraZeneca, Boehringer Ingelheim, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Pfizer among others.
Japan Alzheimer’s Disease Drugs Market Analysis
Japan's Alzheimer’s disease drugs market was valued at $958 Mn in 2022 and is estimated to expand at a CAGR of 8.92% from 2022-30 and will reach $1899 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Daiichi Sankyo Company, Eisai Co., Eli Lilly and Company, Johnson and Johnson., Novartis AG, Pfizer, Takeda Pharmaceutical, Chugai Pharmaceutical, Astellas Pharma, Otsuka Holdings Co, Shionogi & Co among others.
North America Alzheimer’s Disease Drugs Market Analysis
North America Alzheimer’s disease drugs market was valued at $7.71 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.42% from 2022 to 2030 and will reach $13.67 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the development of drugs, the aging population. The market is segmented by drug classes and by distribution channels. Some key players in this market are Amgen, Eisai Co., Eli Lilly and Company, Roche and Johnson, and Johnson among others.
US Alzheimer’s Disease Drugs Market Analysis
The US Alzheimer’s disease drugs market was valued at $6.48 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.42% from 2022 to 2030 and will reach $10.65 Bn in 2030. One of the main reasons propelling the growth of this market is government support, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AstraZeneca, Biogen, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer and Teva Pharmaceutical among others.
Brazil Anemia Drugs Market Analysis
Brazil's Anemia drugs market was valued at $400 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.9% from 2022 to 2030 and will reach $850 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Cristalia Pharma, Ache, EMS Pharma, Eurofarma, BioLab Pharma, Roche, and Pfizer among others.
China Anemia Drugs Market Analysis
China's Anemia drugs market was valued at 1.28 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.4% from 2022 to 2030 and will reach $2.83 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in income and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Roche, Novartis, Sanofi, Shanghai Pharmaceuticals, Sinopharm Group, Jiangsu Hengrui Medicine, and Guangzhou Baiyunshan Pharmaceutical among others.
Europe Anemia Drugs Market Analysis
Europe's Anemia drugs market was valued at $3.04 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.64% from 2022 to 2030 and will reach $5.47 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Amgen, AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi among others.
France Anemia Drugs Market Analysis
France's Anemia drugs market was valued at 439 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030 and will reach $807 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the increase in chronic diseases. The market is segmented by type, drug, and distribution channel. Some key players in this market are Amgen, Aspen, AstraZeneca, Bristol Myers Squibb, Chiesi Farmaceutici, Curium, and Daiichi Sankyo Co.
Germany Anemia Drugs Market Analysis
Germany's Anemia drugs market was valued at $585 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.1% from 2022-30 and will reach $1012 Mn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic illness and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are 1A Pharma, 3B Pharmaceuticals, Abbott, AbbVie Germany, Abnova, AbZ-Pharma, Accord Healthcare, Amgen, and Pfizer among others.
Global Anemia Drugs Market Analysis
The Global Anemia drugs market was valued at $15.98 Bn in 2022 and is estimated to expand at a CAGR of 8.9% from 2022-30 and will reach $31.6 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Pieris Pharmaceuticals, GlaxoSmithKline, Amgen, Bayer AG, Biocon, Takeda Pharmaceutical, Sanofi, and bluebird bio among others.
India Anemia Drugs Market Analysis
India's Anemia drugs market was valued at $291 Mn in 2022 and is estimated to expand at a CAGR of 11.9% from 2022-30 and will reach $714 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Sun Pharmaceutical Industries, Cipla, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, and Alkem Laboratories among others.
